ARCHIVES

In Brief: Henney Names Acting Director Of DRCCA: House Bill Would Slash Deeply Into Research Using Animals

This article is from The Cancer Letter archive.

Vol. 07 No. 37 | September 11, 1981

Download PDF Visit The Full Archive

Related Articles

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

DCBD Board Approves Concept for Astrocytoma Molecular Probes

July 22, 1988

DeVita, Greenwald Assure Centers They’ll Get More Money for Cancer Control

May 11, 1984

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004

NCI Cooperative Group Clinical Trials Approved

August 27, 2010

Funding NCI Bypass Budget The “Very Least” Congress Could Do, Congressman Durbin Says

July 13, 1990